Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Form 8 (OPD)

27 Sep 2013 10:15

RNS Number : 1003P
Centaur Media PLC
27 September 2013
 



FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer making the disclosure:

Centaur Media plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each party to the offer

Centaur Media plc

(d) Is the party to the offer making the disclosure the offeror or the offeree?

OFFEREE

(e) Date position held:

27 September 2013

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

N/A

Nil

N/A

(2) Derivatives (other than options):

Nil

N/A

Nil

N/A

(3) Options and agreements to purchase/sell:

Nil

N/A

Nil

N/A

 

TOTAL:

Nil

N/A

Nil

N/A

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

Nil

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(c) Irrevocable commitments and letters of intent

 

Details of any irrevocable commitments or letters of intent procured by the party to the offer making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of the Code):

None

 

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe of any person acting in concert with the party to the offer making the disclosure:

 

Director

Number of shares held

Ordinary shares

Deferred shares

JPE Taylor

750,000

400,000

MH Kerswell

259,375

Nil

C Satterthwaite

95,942

Nil

C Morrison

455,000

400,000

R Boyle

80,000

Nil

R Miskin

Nil

Nil

800,000 deferred shares of 10p each carry restricted voting rights and carry no right to receive a dividend payment.

The following directors of the Company have the following beneficial interests in the shares in the Company pursuant to incentive/bonus plans/option schemes:

MH Kerswell

Details

Grant date

Shares

Class

Expiry date

Exercise price

SELTIP

12/09/2012

43,394

Ordinary

15/09/2022

Nil

SELTIP

17/09/2013

10,979

Ordinary

15/09/2023

Nil

Retention options

30/12/2011

85,000

Ordinary

31/12/2014

Nil

 

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

27 September 2013

Contact name:

Claire Baty

Telephone number:

+44 (0)20 7970 4506

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEEAPNXASSDEEF
Date   Source Headline
21st Apr 20268:00 amRNSCancellation - Centaur Media PLC
20th Apr 20265:52 pmRNSHolding(s) in Company
16th Apr 20269:41 amRNSHolding(s) in Company
16th Apr 20269:39 amRNSHolding(s) in Company
16th Apr 20269:37 amRNSHolding(s) in Company
16th Apr 20269:36 amRNSHolding(s) in Company
7th Apr 20265:45 pmRNSHolding(s) in Company
7th Apr 20267:00 amRNSHolding(s) in Company
1st Apr 20264:52 pmRNSHolding(s) in Company
1st Apr 20264:41 pmRNSHolding(s) in Company
31st Mar 20264:23 pmRNSHolding(s) in Company
31st Mar 202611:15 amRNSHolding(s) in Company
30th Mar 20264:44 pmRNSHolding(s) in Company
30th Mar 202611:19 amRNSHolding(s) in Company
30th Mar 202611:06 amRNSHolding(s) in Company
27th Mar 20262:30 pmRNSHolding(s) in Company
27th Mar 20262:09 pmRNSHolding(s) in Company
27th Mar 20262:09 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSResult of Tender Offer
23rd Mar 202612:08 pmRNSUpdate on Tender Offer
17th Mar 20261:25 pmRNSResult of Court Hearing
26th Feb 20267:00 amRNSResult of General Meeting
18th Feb 20267:00 amRNSStrategic Partnership
10th Feb 20262:44 pmRNSHolding(s) in Company
5th Feb 20263:59 pmRNSHolding(s) in Company
4th Feb 202611:24 amRNSHolding(s) in Company
30th Jan 20267:00 amRNSTender Offer
6th Jan 20267:00 amRNSTender offer update and sale of Econsultancy
24th Nov 202510:57 amRNSChange of Registered Office
29th Oct 20258:28 amRNSUpdate on Return of Capital
22nd Oct 20254:14 pmRNSHolding(s) in Company
22nd Oct 202512:03 pmRNSHolding(s) in Company
21st Oct 20254:39 pmRNSHolding(s) in Company
21st Oct 20252:12 pmRNSHolding(s) in Company
13th Oct 20257:00 amRNSDirector/PDMR Shareholding
9th Oct 20255:15 pmRNSDirector/PDMR Shareholding
8th Oct 20252:00 pmRNSSale of The Lawyer
25th Sep 20257:00 amRNSAgreement for the sale of Marketing Week
17th Sep 20257:00 amRNSInterim results for the 6 months ended 30 Jun 2025
11th Sep 20257:00 amRNSConditional agreement for the sale of The Lawyer
5th Sep 20252:00 pmRNSHolding(s) in Company
27th Aug 202512:30 pmRNSHolding(s) in Company
19th Aug 20259:39 amRNSHolding(s) in Company
18th Jul 202511:30 amRNSSale of MiniMBA and Notice of Results
25th Jun 20257:00 amRNSConditional agreement for the sale of MiniMBA
19th Jun 20257:00 amRNSExtension to Exclusivity
22nd May 202512:00 pmRNSDirector/PDMR Shareholding
9th May 20258:16 amRNSResponse to Media Speculation
8th May 202512:33 pmRNSResult of AGM
22nd Apr 202512:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.